2nd Quarter - Report
ARENTFOX SCHIFF LLP for CSL BEHRING
Firm
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Orphan drug exclusion within the pharmaceutical tax in the Patient Protection and Affordable Care Act
Foreign entity interest: CSL Limited, identified in the LD-1, is interested in U.S. tax policies that may affect the business of its subsidiary CSL Behring.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PHILIP ENGLISH | — |
| LAURA EUGSTER DOYLE New | Legislative Director to Rep. Philip English |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.